{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:09:53Z","timestamp":1789765793363,"version":"4.0.1"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109667","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T23:04:15Z","timestamp":1771801455000},"page":"109667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Structure-guided discovery of 4-phenyl-5-p-tolyloxymethyl-4H-1,2,4-triazole thioethers as 15-lipoxygenase inhibitors using integrated in vitro, structure-activity relationship, in silico, cytotoxicity towards MCF-7 cell line, DNA docking and MD simulation methods"],"prefix":"10.1016","volume":"173","author":[{"given":"Deeba","family":"Nawaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Momen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash Karkada","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naheed","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bioorg.2026.109667_bb0005","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.3390\/ijms24108838","article-title":"Polyunsaturated fatty acids: conversion to lipid mediators, roles in inflammatory diseases and dietary sources","volume":"24","author":"Harwood","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109667_bb0010","first-page":"331","article-title":"5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease, Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of","volume":"1851","author":"R\u00e5dmark","year":"2015","journal-title":"Lipids"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109667_bb0015","first-page":"308","article-title":"Mammalian lipoxygenases and their biological relevance, Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of","volume":"1851","author":"Kuhn","year":"2015","journal-title":"Lipids"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109667_bb0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.37349\/eaa.2024.00063","article-title":"Deciphering the role of 12\/15-lipoxygenase in asthma: insights into mitochondrial dysfunction and therapeutic implications","volume":"2","author":"Greeshma","year":"2024","journal-title":"Exploration of Asthma Allergy"},{"key":"10.1016\/j.bioorg.2026.109667_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.plipres.2018.11.001","article-title":"Emerging role of 12\/15-Lipoxygenase (ALOX15) in human pathologies","volume":"73","author":"Singh","year":"2019","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109667_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.plefa.2006.01.009","article-title":"Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer","volume":"74","author":"Jiang","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0035","first-page":"L196","article-title":"15-Lipoxygenase-1 induces expression and release of chemokines in cultured human lung epithelial cells","volume":"297","author":"Liu","year":"2009","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.bioorg.2026.109667_bb0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fphar.2019.00719","article-title":"Regulation and functions of 15-lipoxygenases in human macrophages","volume":"10","author":"Snodgrass","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109667_bb0045","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/cancers6031500","article-title":"Inflammation, cancer and oxidative lipoxygenase activity are intimately linked","volume":"6","author":"Wisastra","year":"2014","journal-title":"Cancers"},{"issue":"04","key":"10.1016\/j.bioorg.2026.109667_bb0050","article-title":"Linoleic acid metabolite, 13-S-hydroxyoctadecadienoic acid, suppresses cancer cell growth by inhibiting mTOR","volume":"2025","author":"Park","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.bioorg.2026.109667_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.prostaglandins.2017.01.002","article-title":"ALOX15 as a suppressor of inflammation and cancer: Lost in the link","volume":"132","author":"Tian","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"31","key":"10.1016\/j.bioorg.2026.109667_bb0060","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.2174\/1381612826666210101153216","article-title":"Lipoxygenase (LOX) pathway: a promising target to combat cancer","volume":"27","author":"Vishnupriya","year":"2021","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109667_bb0065","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00280-021-04343-w","article-title":"Zileuton inhibits arachidonate-5-lipoxygenase to exert antitumor effects in preclinical cervical cancer models","volume":"88","author":"Li","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109667_bb0070","doi-asserted-by":"crossref","DOI":"10.12996\/gmj.2025.4388","article-title":"Cyclooxygenases and lipoxygenases in cancer drug resistance","author":"Kazan","year":"2025","journal-title":"Gazi Med. J."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.plipres.2010.10.005","article-title":"Functional and pathological roles of the 12-and 15-lipoxygenases","volume":"50","author":"Dobrian","year":"2011","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109667_bb0080","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10787-018-0489-6","article-title":"Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer","volume":"26","author":"Kennedy","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109667_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.122.001631","article-title":"Cyclooxygenase inhibitors and cancer: the missing pieces","volume":"386","author":"Patrono","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0090","first-page":"1","article-title":"Modulating the JAK\/STAT pathway with natural products: potential and challenges in cancer therapy, Discover","volume":"16","author":"Nair","year":"2025","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109667_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.3944","article-title":"Caspase-driven cancer therapies: Navigating the bridge between lab discoveries and clinical applications","volume":"42","author":"Allani","year":"2024","journal-title":"Cell Biochem. Funct."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109667_bb0100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/1120009X.2023.2278014","article-title":"Recent advances in caspase-3, breast cancer, and traditional Chinese medicine: a review","volume":"36","author":"Dou","year":"2024","journal-title":"J. Chemother."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109667_bb0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The Nuclear factor kappa B (NF-kB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2021","journal-title":"Genes Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109667_bb0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jgh.15184","article-title":"5-lipoxygenase promotes epithelial\u2013mesenchymal transition through the ERK signaling pathway in gastric cancer","volume":"36","author":"Lin","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioorg.2026.109667_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117590","article-title":"Targeted modulation of myeloid-derived suppressor cells in the tumor microenvironment: implications for cancer therapy","volume":"180","author":"Qi","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"23","key":"10.1016\/j.bioorg.2026.109667_bb0120","doi-asserted-by":"crossref","first-page":"35454","DOI":"10.18632\/oncotarget.7721","article-title":"Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target","volume":"7","author":"Steven","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12944-019-1089-1","article-title":"Up-regulation of 15-lipoxygenase enzymes and products in functional and non-functional pituitary adenomas","volume":"18","author":"Barooni","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bioorg.2026.109667_bb0130","series-title":"20-Hydroxyeicosatetraenoic acid (20-HETE): bioactions, receptors, vascular function, cardiometabolic disease and beyond, Advances in Pharmacology","first-page":"229","author":"Pascale","year":"2023"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/embr.201337983","article-title":"The I\u03baB kinase complex in NF-\u03baB regulation and beyond","volume":"15","author":"Hinz","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bioorg.2026.109667_bb0145","first-page":"1","article-title":"NF-\u03baB in inflammation and cancer","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1568010043483917","article-title":"Drugs that target lipoxygenases and leukotrienes as emerging therapies for asthma and cancer","volume":"3","author":"Poff","year":"2004","journal-title":"Current Drug Targets-Inflammation Allergy"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0155","first-page":"14","article-title":"Chemoprevention of breast cancer by cyclooxygenase and lipoxygenase inhibitors","volume":"2","author":"Harris","year":"2020","journal-title":"World Academy Sci. J."},{"issue":"37","key":"10.1016\/j.bioorg.2026.109667_bb0160","doi-asserted-by":"crossref","first-page":"34545","DOI":"10.1074\/jbc.M100280200","article-title":"15-Lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor \u03b3 via the MAPK signaling pathway","volume":"276","author":"Hsi","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0165","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12944-021-01599-2","article-title":"15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged sword","volume":"20","author":"Vaezi","year":"2021","journal-title":"Lipids Health Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109667_bb0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/156802607779941341","article-title":"Dual acting anti-inflammatory drugs","volume":"7","author":"Leone","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14756360903524304","article-title":"Pharmacological significance of triazole scaffold","volume":"26","author":"Kharb","year":"2011","journal-title":"J. Enzyme Inhibition Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105261","article-title":"Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies","volume":"115","author":"Shahid","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2015.11.013","article-title":"Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy","volume":"108","author":"Cai","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2026.109667_bb0190","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.3390\/molecules29246036","article-title":"Search for new compounds with anti-inflammatory activity among 1,2,4-triazole derivatives","volume":"29","author":"Glomb","year":"2024","journal-title":"Molecules"},{"issue":"44","key":"10.1016\/j.bioorg.2026.109667_bb0195","first-page":"14210","article-title":"Evaluation of ethylated phenylcarbamoylazinane-1,2,4-triazole amides derivatives as 15-lipoxygenase inhibitors together with cytotoxic","volume":"5","author":"Muzaffar","year":"2020","journal-title":"ADME Mol. Model. Stud. ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109667_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2021.153518","article-title":"Recent advances in the chemistry of 1,2,4-triazoles: Synthesis, reactivity and biological activities","volume":"86","author":"Abdelli","year":"2021","journal-title":"Tetrahedron Lett."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109667_bb0205","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1039\/c3cs60386e","article-title":"Beyond click chemistry-supramolecular interactions of 1,2,3-triazoles","volume":"43","author":"Schulze","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2026.109667_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.926723","article-title":"Fluorinated triazoles as privileged potential candidates in drug development-focusing on their biological and pharmaceutical properties","volume":"10","author":"Ullah","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112652","article-title":"An insight on medicinal attributes of 1,2,4-triazoles","volume":"205","author":"Aggarwal","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"42","key":"10.1016\/j.bioorg.2026.109667_bb0220","doi-asserted-by":"crossref","first-page":"36945","DOI":"10.1021\/acsomega.2c04883","article-title":"Versatile synthetic platform for 1, 2, 3-triazole chemistry","volume":"7","author":"Vala","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.109667_bb0225","article-title":"Multimodal evaluation of lipoxygenase-targeting NSAIDs using integrated in vitro, SAR, in silico, cytotoxicity towards MCF-7 cell line, DNA docking and MD simulation approaches","volume":"143665","author":"Iqbal","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2026.109667_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40064-016-2052-5","article-title":"Synthesis, anti-inflammatory, bactericidal activities and docking studies of novel 1,2,3-triazoles derived from ibuprofen using click chemistry","volume":"5","author":"Angajala","year":"2016","journal-title":"SpringerPlus"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109667_bb0235","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/ph14030224","article-title":"1, 2, 4-Triazoles as important antibacterial agents","volume":"14","author":"Strzelecka","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.bioorg.2026.109667_bb0240","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1016\/j.bmcl.2008.04.056","article-title":"Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents","volume":"18","author":"Liu","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0245","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3762\/bjoc.7.79","article-title":"Advances in synthetic approach to and antifungal activity of triazoles","volume":"7","author":"Shalini","year":"2011","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0250","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijbiomac.2013.10.023","article-title":"Synthesis and antifungal properties of (4-tolyloxy)-pyrimidyl-\u03b1-aminophosphonates chitosan derivatives","volume":"63","author":"Qin","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2026.109667_bb0255","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejmech.2015.02.027","article-title":"Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity","volume":"93","author":"Chinthala","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0260","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ejmech.2017.08.057","article-title":"Asymmetric synthesis of novel triazole derivatives and their in vitro antiviral activity and mechanism of action","volume":"139","author":"Cao","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2019.02.012","article-title":"Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase","volume":"167","author":"AlFadly","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0270","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2011.10.029","article-title":"Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo\/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase\/lipoxygenase inhibitors","volume":"47","author":"Eleftheriou","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112439","article-title":"Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases","volume":"200","author":"Elzahhar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109667_bb0280","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s13738-022-02733-2","article-title":"Vetting of new N-furfurylated p-chlorophenyl-1,2,4-triazole acetamides as lipoxygenase inhibitors assisted with in vitro and in silico studies","volume":"20","author":"Riaz","year":"2023","journal-title":"J. Iran. Chem. Soc."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109667_bb0285","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s13738-021-02231-x","article-title":"A review on \u2018triazoles\u2019: Their chemistry, synthesis and pharmacological potentials","volume":"18","author":"Dixit","year":"2021","journal-title":"J. Iran. Chem. Soc."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109667_bb0290","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.ejmech.2011.03.051","article-title":"Inhibition of \u03b1-glucosidase and \u03b1-amylase by diaryl derivatives of imidazole-thione and 1,2,4-triazole-thiol","volume":"46","author":"Balba","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0295","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejmech.2019.03.047","article-title":"Design, synthesis and biological evaluation of novel uracil derivatives bearing 1,2,3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs","volume":"171","author":"Lu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109667_bb0300","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1007\/s11696-023-02718-2","article-title":"Potential role of hydrazinyl 1,2,4-triazoles derivatives as acetylcholinesterase inhibitors: synthesis, biological evaluation, kinetics mechanism and molecular docking and simulation studies","volume":"77","author":"Mahesar","year":"2023","journal-title":"Chem. Pap."},{"key":"10.1016\/j.bioorg.2026.109667_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2020.106411","article-title":"An overview of lipoxygenase inhibitors with approach of in vivo studies","volume":"148","author":"Orafaie","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bioorg.2026.109667_bb0310","article-title":"Design, synthesis, and molecular modeling of new 1,2,4-triazole-containing indole compounds as aromatase antagonists for the treatment of breast cancer","volume":"108677","author":"Elrashedy","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2026.109667_bb0315","doi-asserted-by":"crossref","first-page":"16413","DOI":"10.1039\/D3RA01888A","article-title":"Current status of N-, O-, S-heterocycles as potential alkaline phosphatase inhibitors: a medicinal chemistry overview","volume":"13","author":"Jassas","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.109667_bb0320","first-page":"1","article-title":"In silico strategies to recognize pharmacological constraints contrary to COX-2 and 5-LOX","author":"Neha","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"24","key":"10.1016\/j.bioorg.2026.109667_bb0325","doi-asserted-by":"crossref","first-page":"15549","DOI":"10.1080\/07391102.2023.2190807","article-title":"Investigations of p-tolyloxy-1,3,4-oxadiazole propionamides as soybean 15-lipoxygenase inhibitors in comforting with in vitro and in silico studies","volume":"41","author":"Bashir","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"18","key":"10.1016\/j.bioorg.2026.109667_bb0330","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41388-024-03016-1","article-title":"The role of human 5-Lipoxygenase (5-LO) in carcinogenesis-a question of canonical and non-canonical functions","volume":"43","author":"Kahnt","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.109667_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139963","article-title":"Exploration of 4-tolyl-5-(p-tolyloxymethyl)-4H-1,2,4-triazole thioethers as potent 15-LOX inhibitors supported by in vitro, in silico, MD simulation and DNA binding studies","volume":"1321","author":"Iqbal","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109667_bb0340","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bmcl.2016.02.008","article-title":"Synthesis and anti-inflammatory activity evaluation of a novel series of 6-phenoxy-[1,2,4]triazolo[3,4-a]phthalazine-3-carboxamide derivatives","volume":"26","author":"Liu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109667_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128137","article-title":"2-Chloro-7-methyl-3-((4-((p-tolyloxy) methyl)-1H-1,2,3-triazol-1-yl)methyl)quinoline: Crystal structure, hydrogen bonding and anti-bacterial activity","volume":"1212","author":"Ghosh","year":"2020","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109667_bb0350","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1080\/07391102.2020.1726817","volume":"39","author":"Wu","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0355","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/10406638.2023.2174997","article-title":"Synthesis, structural investigations, DFT calculations, and molecular docking studies of novel 2-(substituted-aryloxymethyl)-5-(pyridin-4-yl)-1,3,4-oxadiazoles: Highly potential InhA and cytochrome c peroxidase inhibitors","volume":"44","author":"Datar","year":"2024","journal-title":"Polycycl. Aromat. Compd."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109667_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/crat.202000100","article-title":"Design, synthesis, in silico analysis, and structural study of 4,6-dimethyl-2-(3-(p-tolyloxy)propoxy)nicotinonitrile fleximer","volume":"55","author":"Dowarah","year":"2020","journal-title":"Cryst. Res. Technol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0365","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00044-020-02655-9","article-title":"Novel approach of multi-targeted thiazoles and thiazolidenes toward anti-inflammatory and anticancer therapy-dual inhibition of COX-2 and 5-LOX enzymes","volume":"30","author":"Sl","year":"2021","journal-title":"Med. Chem. Res."},{"issue":"17","key":"10.1016\/j.bioorg.2026.109667_bb0370","first-page":"3745","article-title":"5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design","volume":"27","author":"Sinha","year":"2019","journal-title":"SAR Mech. Based Approach Bio. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0375","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109667_bb0380","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109667_bb0385","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: A multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0390","volume":"version 5","author":"Dennington","year":"2009","journal-title":"GaussView"},{"issue":"14","key":"10.1016\/j.bioorg.2026.109667_bb0395","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.3390\/molecules27144606","article-title":"Design, synthesis, docking, DFT, MD simulation studies of a new nicotinamide-based derivative: In vitro anticancer and VEGFR-2 inhibitory effects","volume":"27","author":"Elkaeed","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109667_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130299","article-title":"New DMAP meso-arylporphyrin Magnesium (II) complex. spectroscopic, cyclic voltammetry and X-ray molecular structure characterization. DFT, DOS and MEP calculations and antioxidant and antifungal activities","volume":"1236","author":"Fradi","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109667_bb0405","article-title":"Utilization of pyrazole-perimidine hybrids bearing different substituents as corrosion inhibitors for 304 stainless steel in acidic media","volume":"1262","author":"\u00d6zlem","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109667_bb0410","doi-asserted-by":"crossref","first-page":"10568","DOI":"10.3389\/or.2022.10568","article-title":"NF-\u03baB signaling in tumor pathways focusing on breast and ovarian cancer","volume":"16","author":"Devanaboyina","year":"2022","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.bioorg.2026.109667_bb0415","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ejmech.2018.08.010","article-title":"MMB triazole analogs are potent NF-\u03baB inhibitors and anti-cancer agents against both hematological and solid tumor cells","volume":"157","author":"Janganati","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109667_bb0420","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4155\/fmc-2023-0261","article-title":"The discovery of a novel I\u03baB kinase \u03b2 inhibitor based on pharmacophore modeling, virtual screening and biological evaluation","volume":"16","author":"Li","year":"2024","journal-title":"Future Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109667_bb0425","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/biomedicines11061662","article-title":"Methyl-thiol-bridged oxadiazole and triazole heterocycles as inhibitors of NF-\u03baB in chronic myelogenous leukemia cells","volume":"11","author":"Basappa","year":"2023","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.bioorg.2026.109667_bb0430","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70059","article-title":"Recent advances in 1,2,4-triazole-based anticancer agents: Structural optimization, mechanisms, and therapeutic potential (2022-2025)","volume":"358","author":"Naeem","year":"2025","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2026.109667_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molliq.2017.10.017","article-title":"Deciphering the interaction of methotrexate with DNA: Spectroscopic and molecular docking study","volume":"248","author":"Yang","year":"2017","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2026.109667_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.115491","article-title":"Insights into the binding properties of calf thymus DNA with lopinavir from spectroscopic and computational studies","volume":"328","author":"Kou","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2026.109667_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.tca.2020.178856","article-title":"S.K.C, Binding behaviour of aminoglycoside drug kanamycin with calf thymus DNA: Thermodynamic, spectroscopic and molecular modelling studies","volume":"697","author":"Keswani","year":"2021","journal-title":"Thermochimica Acta"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109667_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24470","article-title":"Anti-enzymatic and DNA docking studies of montelukast: A multifaceted molecular scaffold with in vitro investigations, molecular expression analysis and molecular dynamics simulations","volume":"10","author":"Abdullah","year":"2024","journal-title":"Heliyon"},{"issue":"23","key":"10.1016\/j.bioorg.2026.109667_bb0455","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.3390\/molecules25235662","article-title":"Quinolones: Mechanism, lethality and their contributions to antibiotic resistance","volume":"25","author":"Bush","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0460","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/bio.3696","article-title":"Comparative study of two cephalosporin antibiotics binding to calf thymus DNA by multispectroscopy, electrochemistry, and molecular docking","volume":"35","author":"Huang","year":"2020","journal-title":"Luminescence"},{"issue":"36","key":"10.1016\/j.bioorg.2026.109667_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202202278","article-title":"DNA-binding studies of ofloxacin using a series of spectroscopic, electrochemical techniques and in silico approaches","volume":"7","author":"Cesme","year":"2022","journal-title":"ChemistrySelect"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109667_bb0470","doi-asserted-by":"crossref","first-page":"14005","DOI":"10.1021\/acsomega.3c09355","article-title":"Antiurease activity of antibiotics: in vitro, in silico, structure activity relationship, and MD simulations of cephalosporins and fluoroquinolones","volume":"9","author":"Aslam","year":"2024","journal-title":"ACS Omega"},{"issue":"47","key":"10.1016\/j.bioorg.2026.109667_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202505316","article-title":"Exploring antiurease activity of antibiotics: Insights from in vitro, SAR, in silico, DNA docking, and MD simulation studies","volume":"10","author":"Mujtaba","year":"2025","journal-title":"ChemistrySelect"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109667_bb0480","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1073\/pnas.78.4.2179","article-title":"Structure of a B-DNA dodecamer: conformation and dynamics","volume":"78","author":"Drew","year":"1981","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.109667_bb0485","article-title":"Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: Design, synthesis","volume":"143","author":"Nawaz","year":"2024","journal-title":"DFT Calculat. Mol. Dock. Stud. Bioorganic Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2026.109667_bb0490","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.bmcl.2018.05.020","article-title":"Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo[1,5-a]pyrimidines in human breast cancer cells","volume":"28","author":"Gilandoust","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0495","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s11030-024-10858-0","article-title":"An updated review on 1,2,3-\/1,2,4-triazoles: synthesis and diverse range of biological potential","volume":"29","author":"Raman","year":"2025","journal-title":"Mol. Divers."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109667_bb0500","first-page":"2492","article-title":"A comprehensive review of 1, 2, 3 & 1, 2, 4 triazoleanalogs for their versatile biological activities","volume":"6","author":"Singh","year":"2024","journal-title":"African J. Biol. Sci."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109667_bb0505","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.3390\/molecules27155035","article-title":"Anti-inflammatory activity of 4-(4-(heptyloxy) phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via repression of MAPK\/NF-\u03baB signaling pathways in \u03b2-amyloid-induced Alzheimer\u2019s disease models","volume":"27","author":"An","year":"2022","journal-title":"Molecules"},{"issue":"1-3","key":"10.1016\/j.bioorg.2026.109667_bb0510","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejphar.2013.07.010","article-title":"Enhancement of PLGF production by 15-(S)-HETE via PI3K-Akt, NF-\u03baB and COX-2 pathways in rheumatoid arthritis synovial fibroblast","volume":"714","author":"Wu","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0515","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41467-023-43554-y","article-title":"15-Lipoxygenase promotes resolution of inflammation in lymphedema by controlling Treg cell function through IFN-\u03b2","volume":"15","author":"Zamora","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109667_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105243","article-title":"Identification of phenylcarbamoylazinane-1,3,4-oxadiazole amides as lipoxygenase inhibitors with expression analysis and in silico studies","volume":"115","author":"Bashir","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106144","article-title":"Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies","volume":"129","author":"Bashir","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132721","article-title":"Identifying alkaline phosphatase inhibitory potential of cyclooxygenase-2 inhibitors: Insights from molecular docking, MD simulations, molecular expression analysis in MCF-7 breast cancer cell line and in vitro investigations","volume":"277","author":"Hussain","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"27","key":"10.1016\/j.bioorg.2026.109667_bb0535","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1002\/jcc.26012","article-title":"DFT calculations on molecular structures, HOMO\u2013LUMO study, reactivity descriptors and spectral analyses of newly synthesized diorganotin (IV) 2-chloridophenylacetohydroxamate complexes","volume":"40","author":"Choudhary","year":"2019","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109667_bb0540","series-title":"Gaussian09","author":"Frisch","year":"2009"},{"key":"10.1016\/j.bioorg.2026.109667_bb0545","series-title":"GaussView 6.0. 16, Semichem Inc.: Shawnee Mission, KS, USA","first-page":"143","author":"Dennington","year":"2016"},{"issue":"44","key":"10.1016\/j.bioorg.2026.109667_bb0550","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1021\/ja011759t","article-title":"Three-dimensional structure of a purple lipoxygenase","volume":"123","author":"Skrzypczak-Jankun","year":"2001","journal-title":"J. Am. Chem. Soc."},{"issue":"31","key":"10.1016\/j.bioorg.2026.109667_bb0555","doi-asserted-by":"crossref","first-page":"22758","DOI":"10.1074\/jbc.M113.482596","article-title":"Crystal structure of a human I\u03baB kinase \u03b2 asymmetric dimer","volume":"288","author":"Liu","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"6665","key":"10.1016\/j.bioorg.2026.109667_bb0560","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/34956","article-title":"Crystal structure of p50\/p65 heterodimer of transcription factor NF-\u03baB bound to DNA","volume":"391","author":"Chen","year":"1998","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109667_bb0565","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"issue":"6364","key":"10.1016\/j.bioorg.2026.109667_bb0570","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/356083a0","article-title":"Assessment of protein models with three-dimensional profiles","volume":"356","author":"Luthy","year":"1992","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bioorg.2026.109667_bb0580","series-title":"Semichem, GaussView (Version 5). Shawnee Mission","author":"Dennington","year":"2009"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109667_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13062-020-00267-2","article-title":"AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4","volume":"15","author":"Valdes-Tresanco","year":"2020","journal-title":"Biol. Direct"},{"key":"10.1016\/j.bioorg.2026.109667_bb0590","series-title":"PyMOL","author":"Schrodinger","year":"2020"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109667_bb0595","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1021\/ci800063v","article-title":"Molecular docking of intercalators and groove-binders to nucleic acids using Autodock and Surflex","volume":"48","author":"Holt","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.109667_bb0600","article-title":"GROMACS 2020.6 Source code","author":"Spoel","year":"2021","journal-title":"Zenodo"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:55:17Z","timestamp":1772891717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826002038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":120,"alternative-id":["S0045206826002038"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109667","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided discovery of 4-phenyl-5-p-tolyloxymethyl-4H-1,2,4-triazole thioethers as 15-lipoxygenase inhibitors using integrated in vitro, structure-activity relationship, in silico, cytotoxicity towards MCF-7 cell line, DNA docking and MD simulation methods","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109667"}}